AG-24322

DB13035InvestigationalSmall molecule

AG-024322 has been used in trials studying the treatment of Neoplasms and Lymphoma, Non-Hodgkin.

Mechanism: Pharmacologically active on Cyclin-dependent kinase 1, Cyclin-dependent kinase 4, and Cyclin-dependent kinase 2
Curator reviewed
Formula / weight: C₂₃H₂₀F₂N₆ · 418.452 g/mol (avg)
Code names: AG-024322

Resolves to

Compound

Structure

InChIKeyMEKASOQEXYKAKM-UHFFFAOYSA-NSMILESCCNCC1=CN=CC(=C1C)C1=CC=C2NN=C(C3=NC4=C(F)C=C(F)C=C4N3)C2=C1

Targets

What you can answer from here — as of June 15, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

9+ReferencesStructured and connected to the statements they support

Which drugs share a target with AG-24322, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.